Physician profile
Jullet Han
NPI 1407218050
$104,943.00
in general payments reported to CMS, 2019-2025
18 companies · $40K in 2025
The $40K reported for 2025 was more than what 98% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $237 · 2021: $311 · 2022: $11K · 2023: $14K · 2024: $39K · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $63K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Travel and Lodging: $11K · Food and Beverage: $6,952 · Gift: $31.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $63,250.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,000.00 |
| Travel and Lodging | $10,695.29 |
| Food and Beverage | $6,951.89 |
| Gift | $31.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $102,298.99 | 2022-2025 | Da Vinci Sp, Davinci Xi, Da Vinci Surgical System |
| Boston Scientific Corporation | $764.80 | 2020-2023 | Lithovue, Spectra |
| Urogen Pharma, INC. | $264.97 | 2022-2025 | |
| Procept Biorobotics Corporation | $253.52 | 2023-2025 | Aquabeam Robotic System |
| Ferring Pharmaceuticals INC. | $250.02 | 2024-2025 | Adstiladrin |
| Photocure INC | $241.44 | 2019-2023 | Cysview |
| Histosonics, INC. | $145.32 | 2024 | |
| Progenics Pharmaceuticals, INC. | $125.00 | 2024 | |
| Janssen Biotech, INC. | $122.62 | 2019 | |
| Teleflex LLC | $117.56 | 2022 | |
| Emd Serono, INC. | $83.23 | 2023 | Bavencio |
| Astellas Pharma US INC | $78.43 | 2019 | |
| Stryker Corporation | $71.13 | 2025 | 1788 |
| Abbvie INC. | $35.00 | 2025 | |
| Epizyme, INC. | $24.53 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $24.49 | 2025 | Signia |
| Genzyme Corporation | $21.49 | 2020 | |
| Sk Life Science, INC. | $20.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jullet Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.